Citation Tools

Download PDFPDF
Original research
Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn’s patients: a proteomics-based study

Download to a citation manager

Cite this article as:
Pierre N, Baiwir D, Huynh-Thu VA GETAID (Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif), et al
Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn’s patients: a proteomics-based study